1. Home
  2. PAHC vs INVA Comparison

PAHC vs INVA Comparison

Compare PAHC & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

N/A

Current Price

$48.49

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Innoviva Inc.

INVA

Innoviva Inc.

N/A

Current Price

$22.32

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAHC
INVA
Founded
1946
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
PAHC
INVA
Price
$48.49
$22.32
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
$34.33
$36.50
AVG Volume (30 Days)
232.7K
730.3K
Earning Date
05-06-2026
05-28-2026
Dividend Yield
1.00%
N/A
EPS Growth
1883.33
816.67
EPS
1.32
3.30
Revenue
$833,350,000.00
$217,217,000.00
Revenue This Year
$17.03
$8.78
Revenue Next Year
$3.82
$11.99
P/E Ratio
$36.22
$6.68
Revenue Growth
4.12
62.63
52 Week Low
$16.16
$16.52
52 Week High
$56.30
$25.15

Technical Indicators

Market Signals
Indicator
PAHC
INVA
Relative Strength Index (RSI) 47.64 50.57
Support Level $37.09 $19.16
Resistance Level $56.14 $22.76
Average True Range (ATR) 2.27 0.74
MACD -0.94 -0.25
Stochastic Oscillator 26.88 15.95

Price Performance

Historical Comparison
PAHC
INVA

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Share on Social Networks: